STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the acquisition of Cellular Highways ...

Machine learning models have seeped into the fabric of our lives, from curating playlists to explaining hard concepts in a ...

Micron's tech edge, margin tailwinds, and deep integration into Nvidia’s AI stack signal long-term upside. Click here to read ...

Company enters option agreement with JiKang Therapeutics to in-license novel APJ agonist antibody New composition of matter IP filed for ch ...

Tolerance Bio is targeting an often-overlooked organ — the thymus — with cell therapy to help kids with DiGeorge syndrome, and potentially extend lifespan in adults.

In conversation with Fierce Biotech’s Chris Hayden, Austin Read, head of PPD™ CorEvitas™ Precision Medicine, Thermo Fisher ...

The oncology giant will pay $1.5 billion to co-develop a BioNTech drug that targets the proteins PD-L1 and VEGF, following ...

In this exclusive TechBullion interview, Helen Huang; artist, strategist, and Co-Founder of PixelPack, shares how her ...

In trying to lead before the system could follow, 23andMe outpaced the very guardrails that might have legitimized it”: A ...

The global protein expression technology market is expected to be reach USD 3,011.8 million in 2025 and is likely to expand ...